Answers are grounded in this paper and cite their sources.
Patients with severe COVID-19 may progress to coagulopathy, which is characterized by thrombocytopenia, prolonged PT and aPTT, elevated D-dimer and decreased fibrinogen. Pregnancy itself is also a hypercoagulable state with higher risk of Venous Thromboembolism (VTE), especially after the placental expulsion and the postpartum period, where clotting activity is at its highest. Pregnancy is associated with almost 3 times the risk of thrombotic complications. Despite both acute and chronic complications of VTE, the importance and management of VTE in the context of COVID-19 infections in pregnant women has not been described well. This review was conducted to provide insight into pathophysiology of COVID-19 disease in the context of postpartum period and its clinical implications. Herein, we discuss the underlying pathogenesis of VTE and thrombotic incidences in patients with ongoing SARS-CoV-2 infections and provide strategies to limit morbidity and mortality in the management of these subset of patients in clinical settings.
No takes yet. Share an insight, caveat, or question.
Saleh et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: